Nautilus Biotechnology Featured on NPR’s Marketplace Tech Podcast Segment


Since 2016, Parag Mallick, PhD, Founder and Chief Scientist, and his team at Nautilus have been building a machine that they say will revolutionize biomedicine by helping scientists study proteins in detail and unlocking the secrets of the “dark proteome.” The vast majority of drugs approved by the Food and Drug Administration target proteins, after all.